ATE326949T1 - Verfahren zur herstellung fester dispersionen - Google Patents

Verfahren zur herstellung fester dispersionen

Info

Publication number
ATE326949T1
ATE326949T1 AT01914278T AT01914278T ATE326949T1 AT E326949 T1 ATE326949 T1 AT E326949T1 AT 01914278 T AT01914278 T AT 01914278T AT 01914278 T AT01914278 T AT 01914278T AT E326949 T1 ATE326949 T1 AT E326949T1
Authority
AT
Austria
Prior art keywords
methods
producing solid
solid dispersions
substances
dispersions
Prior art date
Application number
AT01914278T
Other languages
English (en)
Inventor
Arne Brodin
Sylvan Frank
Chao Ye
Original Assignee
Univ Ohio State Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0000934A external-priority patent/SE0000934D0/xx
Application filed by Univ Ohio State Res Found filed Critical Univ Ohio State Res Found
Application granted granted Critical
Publication of ATE326949T1 publication Critical patent/ATE326949T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Colloid Chemistry (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01914278T 2000-03-09 2001-03-08 Verfahren zur herstellung fester dispersionen ATE326949T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18798400P 2000-03-09 2000-03-09
SE0000934A SE0000934D0 (sv) 2000-03-21 2000-03-21 Method of preparing pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ATE326949T1 true ATE326949T1 (de) 2006-06-15

Family

ID=26655029

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01914278T ATE326949T1 (de) 2000-03-09 2001-03-08 Verfahren zur herstellung fester dispersionen

Country Status (11)

Country Link
US (1) US20030104065A1 (de)
EP (1) EP1263413B1 (de)
JP (1) JP2003525895A (de)
AT (1) ATE326949T1 (de)
AU (1) AU2001239625A1 (de)
CY (1) CY1105515T1 (de)
DE (1) DE60119905T2 (de)
DK (1) DK1263413T3 (de)
ES (1) ES2263600T3 (de)
PT (1) PT1263413E (de)
WO (1) WO2001066091A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
DE10358749A1 (de) * 2003-12-12 2005-07-14 Lts Lohmann Therapie-Systeme Ag Darreichungsform zur Bekämpfung von primären Kopfschmerzen
US8475845B2 (en) 2005-07-15 2013-07-02 Map Pharmaceuticals, Inc. Method of particle formation
US20100184744A1 (en) * 2007-07-18 2010-07-22 Feyecon Development & Implementation B.V. Method of preparing a pharmaceutical co-crystal composition
EP2436383B1 (de) * 2009-05-29 2017-07-19 Morishita Jintan Co., Ltd. Oral einnehmbare medizinische zusammensetzung und oral einnehmbare kapsel mit der darin eingekapselten zusammensetzung
JP5941072B2 (ja) * 2011-03-07 2016-06-29 スリーエム イノベイティブ プロパティズ カンパニー マイクロニードルデバイス及び方法
FR2987266B1 (fr) * 2012-02-28 2014-12-19 Debregeas Et Associes Pharma Procede d'obtention d'une composition pharmaceutique a base de modafinil, composition pharmaceutique ainsi obtenue et son application
WO2015071841A1 (en) 2013-11-12 2015-05-21 Druggability Technologies Holdings Limited Complexes of dabigatran and its derivatives, process for the preparation thereof and pharmaceutical compositions containing them
CN108096195B (zh) * 2018-01-08 2020-01-24 中国药科大学 超临界抗溶剂法制备阿齐沙坦固体分散体的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169433A (en) * 1990-07-18 1992-12-08 Formulogics, Inc. Method of preparing mixtures of active ingredients and excipients using liquid carbon dioxide
WO1994008599A1 (en) * 1992-10-14 1994-04-28 The Regents Of The University Of Colorado Ion-pairing of drugs for improved efficacy and delivery
SI9400079B (sl) * 1994-02-15 2003-02-28 Dr. Weidner Eckhard, Dipl. Ing. Postopek in naprava za pridobivanje in frakcioniranje majhnih delcev iz raztopin nasičenih s plinom
WO1998016204A1 (en) * 1996-10-14 1998-04-23 F. Hoffmann-La Roche Ag Process for the manufacture of a pulverous preparation
US5955475A (en) * 1997-06-30 1999-09-21 Endo Pharmaceuticals Inc. Process for manufacturing paroxetine solid dispersions
WO1999052504A1 (en) * 1998-04-09 1999-10-21 F. Hoffmann-La Roche Ag Process for the manufacture of (sub)micron sized particles by dissolving in compressed gas and surfactants
IL140276A0 (en) * 1998-06-19 2002-02-10 Rtp Pharma Inc Processes to generate submicron particles of water-insoluble compounds
US20020041898A1 (en) * 2000-01-05 2002-04-11 Unger Evan C. Novel targeted delivery systems for bioactive agents

Also Published As

Publication number Publication date
DE60119905D1 (de) 2006-06-29
ES2263600T3 (es) 2006-12-16
WO2001066091A1 (en) 2001-09-13
EP1263413B1 (de) 2006-05-24
US20030104065A1 (en) 2003-06-05
JP2003525895A (ja) 2003-09-02
PT1263413E (pt) 2006-08-31
DE60119905T2 (de) 2007-01-11
DK1263413T3 (da) 2006-09-11
EP1263413A1 (de) 2002-12-11
CY1105515T1 (el) 2010-07-28
AU2001239625A1 (en) 2001-09-17

Similar Documents

Publication Publication Date Title
CY1105515T1 (el) Μεθοδος παρασκευης στερεων διασπορων
AR033548A1 (es) Composicion farmaceutica que comprende un inhibidor de lipasa, un procedimiento para su preparacion, equipo transportable a modo de ''kit'', el uso de dicha composicion en la fabricacion de medicamentos, un inhibidor de lipasa y un secuestrante de acidos biliares
CR9704A (es) Composicion farmaceutica de liberacion modificada, proceso de preparacion y metodo para emplear la misma.
WO2007128923A3 (fr) Procede de preparation d'un gel biocompatible a libération contrôlée d'un ou de plusieurs principes actifs peu solubles dans l'eau, gels ainsi obtenus et leur utilisation
BRPI0716436B8 (pt) sistema de liberação controlada e método para fabricação do mesmo
BR0207760A (pt) Composição farmacêutica, uso da mesma, métodos para o tratamento de dor e de inflamação, e, processo para a preparação de uma composição
DE60312333D1 (de) Einen lipophilen wirkstoff enthaltende feste pharmazeutische zusammensetzung sowie deren herstellung
BR9808888A (pt) Formas de dosagem e método de melhorar disfunção erétil masculina
DE69906269T2 (de) Wässriges verfahren zur herstellung fester paroxetin-dispersionen
AR082579A2 (es) Una composicion farmaceutica espontaneamente dispersable para la administracion oral, uso para la preparacion de un medicamento para el tratamiento del cancer, metodo para incrementar los niveles de biodisponibilidad o reducir su variabilidad
ATE410162T1 (de) Verfahren zur herstellung einer fein selbstemulgierbaren pharmazeutischen zusammensetzung
CA2372339A1 (en) Pharmaceutical product comprising the active substance diamorphine, and its use in a process for treating opiate addiction
WO2006007354A3 (en) A drug/polymer complex, preferably ciprofloxacin/hpmc, its method of manufacturing using lyophilization and its use in an osmotic device
MX2008009357A (es) Una composicion solida de taxano liofilizada, un procedimiento para preparar dicha composicion solida, una formulacion farmaceuctica y un conjunto (kit) de dicha formulacion.
WO2002040702A3 (en) Methods for the treatment of cancer and other diseases and methods of developing the same
NO20071354L (no) anvendelse av samme Butylftalid selvemulsifiserene medikamentavgivelsessystem, samt fremgangsmater for fremstilling og anvendelse av samme.
ATE406870T1 (de) Filmförmige, zerfallsfähige zubereitungen zur wirkstoff-freisetzung und verfahren zu deren herstellung
DE60230066D1 (de) Pharmazeutische zusammensetzung zur behandlung von psoriasis und anderen hautkrankheiten
DE50014164D1 (de) Verfahren zur herstellung einer wasserunlöslichen amorphen retardmatrix
ATE289801T1 (de) Verabreichungssystem für wasserunlösliche arzneistoffe
DK1280558T3 (da) Halvfast indgivelsesvehikel og farmaceutiske sammensætninger
DE60218473D1 (de) Verfahren zur herstellung polyvalenter bakteriophagenpräparationen zur behandlung bakterieller infektionen
DE60000286T2 (de) Lipide enthaltende sojaextrakte, verfahren zu deren herstellung und pharmazeutische und kosmetische zusammensetzung
BR0007452A (pt) Uso de melagatrano ou de um derivado farmaceuticamente aceitável ou pró-droga do mesmo, método de tratamento de inflamação, e, formulação farmacêutica para uso no tratamento de inflamação
NO20054417L (no) Fremgangsmate for fremstilling av farmasoytiske preperater i form av fibratholdige tabletter og de derved fremstilte tabletter

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1263413

Country of ref document: EP

REN Ceased due to non-payment of the annual fee